About P&T JournalContacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
Vice President, Group Publisher
Production: Mary Ellen Curry,
Director of Production Services
Circulation: Jackie Ott, Circulation Manager
- 2014 Rate Card & Production Specs
- 2013 Rate Card & Production Specs
- Advertising Due Dates
- BPA Statement
Statement of Purpose
Guidelines for Authors
Clostridium difficile–Associated Diarrhea: A Review and Update on Changes in Disease Virulence and Treatment Response
The authors review the increased incidence of antibiotic-associated diarrhea as well as its pathogenesis, diagnosis, prevention, and treatment.
April D. Miller, PharmD, Kelly M. Smith, PharmD, P. Shane Winstead, PharmD, and Craig A. Martin, PharmD
P&T Around the World
A mysterious illness in several Vietnamese children sets off an investigation that has worldwide implications for vaccine supply chains and safe handling practices.
Peter G. Teichman, MD, MPA, and Nguyen Tri Doan, MD
Epoetin alpha (recombinant human erythropoietin) is effective for anemia in patients with chronic kidney disease or cancer, but not all patients respond favorably. The authors sought to predict which patients would be likely to respond before therapy is begun.
Justin Welch, PharmD, BCPS, Matthew Webb, PharmD, Ji Koo, PharmD, and Curt Doetkott, MS
The author explores the interrelationships of calcium, vitamin D, and phenytoin and their effects on bone health in patients with epilepsy.
Alexander Motylev, RPh, PhD
Cancer progress and a vaccine for vaginal/vulvar cancers are reviewed.
Lawrence M. Prescott, PhD, and Sharon L. Prescott
Dasatinib (Sprycel), bevacizumab plus IV 5-fluorouracil (Avastin), and topotecan injection (Hycamptin) plus cisplatin are discussed.
Marvin M. Goldenberg, PhD, RPh, MS
David Nash, MD, MBA, discusses the Sheffield Teaching Hospitals NHS Foundation Trust and its goal of implementing rational drug therapy in Britain.
David Nash, MD, MBA
Matthew Grissinger, RPh, FASCP, explains how double-checks by a second person can reduce discrepancies and errors in drug prescriptions and specialized regimens for high-risk patients.
Matthew Grissinger, RPh, FASCP
Stephen Barlas takes another look at the Institute of Medicine’s 1999 report, To Err Is Human, and the lack of progress made in reducing medical errors since then.
P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new devices.
Olga Hilas, PharmD, and Lisa Charneski, PharmD, review Fluarix influenza virus vaccine.
Olga Hilas, PharmD, BCPS, and Lisa Charneski, PharmD, BCPS